This study aims to inform how social networks contribute to caregiver well-being and reduce burdens associated with caring for persons living with dementia.
HOSTED BY BANNER ALZHEIMER'S INSTITUTE
This study aims to inform how social networks contribute to caregiver well-being and reduce burdens associated with caring for persons living with dementia.
Researchers are evaluating an investigational* drug called PRX012 in adults aged 55 to 85 years old with mild Alzheimer’s disease to gain information about the potential benefits and risks to participants taking the investigational drug and to see what happens to the investigational drug once inside the body.
*Investigational means that PRX012 is still being tested in clinical trials and has not yet been shown to be safe or effective in treating Alzheimer’s disease or approved by any regulatory authorities.
The BrainHealth Project a landmark scientific study to measure, improve and track one’s own brain fitness. This easy-to-use online platform delivers a unique, science-backed program, accompanied by brain training and live virtual coaching.
This innovative approach to brain training teaches you to focus on your own strengths and performance, empowering you to continue becoming the best version of yourself.
The TRAP-AD study is investigating if an experimental treatment device that uses near-infrared light therapy will lead to improvement in cognition in adults with amnestic Mild Cognitive Impairment (aMCI) and early AD. The treatment, transcranial photobiomodulation (t-PBM), stimulates certain parts of the brain that are thought to be affected in memory impairment.
This study will evaluate, over time, whether the presence of Cardiovascular risk factors contribute to the progression of memory and thinking decline, as well as changes in MRI measures and blood biomarkers.
The WeCareAdvisor is an innovative tool developed by researchers at Drexel University and University of California, Davis to help family caregivers manage common behavioral and psychological symptoms of dementia (like anger, irritability, asking repeated questions, pacing, refusing needed help, and many others). The WeCareAdvisor works on any internet-accessible device, including desktop and laptop computers, tablets, and smartphone and is simple to use.